Livzon Pharmaceutical Group
在场
高管
查看带有其 12 名主要高管的组织结构图
Livzon Pharmaceutical Group 搜索最多的简介
- Yanggang Tang, President and Executive Director
- Baoguo Zhu, Chairman of the Board
- Lijie Cui, Non-Executive Independent Director
高管在Livzon Pharmaceutical Group变化
- Xiong Yu, Non-Executive Director, 已经离开公司 (新闻发布的2024十月15号).
创建提醒
跟踪 Livzon Pharmaceutical Group 的高管变动
药店
Livzon Pharmaceutical Group 拥有 1,835 家竞争者，其中包括 Pfizer (美国(美洲))、Johnson & Johnson (美国(美洲)) 和 Sanofi (法国)。
Popular M&A news in 药店
- Grace Therapeutics将在Oct 24, 2024将其名称改为Grace Therapeutics。 (公布2024十月27号).
- Orasis Pharmaceuticals 刚刚宣布为 78 筹款数百万美元。 (公布2024十月21号).
- Lundbeck has announced the acquisition of Longboard Pharmaceuticals (公布2024十月17号).
药店 行业的其他推荐联系人
消息
Livzon Pharmaceutical Group 的最新新闻稿
- Board Diversity Policy_Sustainable Development_Livzon
- Tax Policy_Sustainable Development_Livzon
- Philanthropy_Sustainable Development_Livzon
- Suppliers_Sustainable Development_Livzon
- Environment, Occupational Health and Safety (EHS)_Sustainable Development_Livzon
- Human Development_Sustainable Development_Livzon
- Business Ethics_Sustainable Development_Livzon
- Livzon Group Won “Top 10 of Private Enterprise in Zhuhai”_Livzon
- Employment system_News Center_Livzon
- A Recombinant SARS-Cov-2 Fusion Protein Vaccine (V-01) developed and manufactured by Livzon has shown good protective effects against the Omicron variant in a phase III clinical booster trial_Livzon
- View more press releases Close
